» Articles » PMID: 34175492

RASopathies: From Germline Mutations to Somatic and Multigenic Diseases

Overview
Journal Biomed J
Publisher Elsevier
Specialty General Medicine
Date 2021 Jun 27
PMID 34175492
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The RAS-RAF-MEK-ERK signaling pathway is vital for different cellular mechanisms including cell proliferation, differentiation and apoptosis. This importance is highlighted by the high prevalence of mutations in RAS or related proteins of the pathway in cancers. More recently, development abnormalities have been linked to various germline mutations in this pathway and called RASopathies. Interestingly, rare disorders such as RAS-associated leukoproliferative diseases and histiocytosis have also been recently linked to multiple mutations in the same pathway, sometimes with the same mutation. This review will focus on germline RASopathies and rare somatic RASopathies and focus on how gain-of-function mutations in the same pathway can lead to various diseases.

Citing Articles

Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome.

De Brouchoven I, Lorand J, Bofferding L, Sorlin A, Van Damme A, Danhaive O Front Pediatr. 2025; 13:1475143.

PMID: 40041314 PMC: 11876372. DOI: 10.3389/fped.2025.1475143.


Noonan Syndrome: Relation of Genotype to Cardiovascular Phenotype-A Multi-Center Retrospective Study.

Ilic N, Krasic S, Maric N, Gasic V, Krstic J, Cvetkovic D Genes (Basel). 2024; 15(11).

PMID: 39596663 PMC: 11594011. DOI: 10.3390/genes15111463.


Somatic mutations in autoinflammatory and autoimmune disease.

Torreggiani S, Castellan F, Aksentijevich I, Beck D Nat Rev Rheumatol. 2024; 20(11):683-698.

PMID: 39394526 DOI: 10.1038/s41584-024-01168-8.


Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome.

Nakamura A, Nomura S, Hara S, Thamamongood T, Maehara T, Nariai T Sci Rep. 2024; 14(1):22720.

PMID: 39367156 PMC: 11452616. DOI: 10.1038/s41598-024-72043-5.


Germline mutations in a G protein identify signaling cross-talk in T cells.

Ham H, Jing H, Lamborn I, Kober M, Koval A, Berchiche Y Science. 2024; 385(6715):eadd8947.

PMID: 39298586 PMC: 11811912. DOI: 10.1126/science.add8947.


References
1.
Cirstea I, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D . A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet. 2009; 42(1):27-9. PMC: 3118669. DOI: 10.1038/ng.497. View

2.
Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T . Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007; 44(12):763-71. PMC: 2652823. DOI: 10.1136/jmg.2007.050450. View

3.
Diamond E, Durham B, Haroche J, Yao Z, Ma J, Parikh S . Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2015; 6(2):154-65. PMC: 4744547. DOI: 10.1158/2159-8290.CD-15-0913. View

4.
Gripp K, Morse L, Axelrad M, Chatfield K, Chidekel A, Dobyns W . Costello syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019; 179(9):1725-1744. PMC: 8238015. DOI: 10.1002/ajmg.a.61270. View

5.
Schubbert S, Zenker M, Rowe S, Boll S, Klein C, Bollag G . Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006; 38(3):331-6. DOI: 10.1038/ng1748. View